Palemo Holdings
2778
Spancrete
5277
Renascience
4889
Oncolys BioPharma
4588
Kitagawa Seiki
6327
JP Stock MarketDetailed Quotes
9663 Nagawa
- 6300
- 00.00%
20min DelayNot Open Jan 22 15:30 JST
103.05BMarket Cap31.75P/E (Static)
6390High6250Low14.50KVolume6300Open6300Pre Close91.28MTurnover829052wk High0.17%Turnover Ratio16.36MShares607052wk Low205.37EPS TTM52.71BFloat Cap13660Historical High31.75P/E (Static)8.37MShs Float330Historical Low198.41EPS LYR2.22%Amplitude60.00Dividend TTM1.64P/B100Lot Size0.95%Div YieldTTM
Nagawa Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.20%8.46B | 2.92%32.58B | -0.58%8.94B | 5.41%8.69B | 4.64%7.78B | 2.65%7.16B | 3.48%31.65B | 2.72%8.99B | 9.26%8.25B | 2.88%7.44B |
| Cost of revenue | 25.62%5.25B | 3.30%19.41B | -2.53%5.44B | 6.23%5.22B | 6.53%4.58B | 4.37%4.18B | 4.01%18.79B | 2.22%5.58B | 11.64%4.91B | 4.22%4.3B |
| Gross profit | 7.81%3.22B | 2.36%13.17B | 2.60%3.51B | 4.17%3.47B | 2.07%3.2B | 0.34%2.98B | 2.72%12.86B | 3.58%3.42B | 5.91%3.34B | 1.06%3.14B |
| Operating expense | 5.28%2.32B | 4.35%8.92B | -2.66%2.27B | 5.13%2.26B | 8.24%2.19B | 7.69%2.2B | 5.77%8.55B | 10.98%2.33B | 8.33%2.15B | -0.20%2.03B |
| Staff costs | ---- | -4.30%3.45B | ---- | ---- | ---- | ---- | 6.00%3.6B | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | 9.02%1.22B | ---- | ---- | ---- | ---- | 15.82%1.12B | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 14.97%599M | ---- | ---- | ---- | ---- | 25.24%521M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 3.84%622M | ---- | ---- | ---- | ---- | 8.71%599M | ---- | ---- | ---- |
| Depreciation and amortization | ---- | 18.80%278M | ---- | ---- | ---- | ---- | 10.90%234M | ---- | ---- | ---- |
| -Depreciation | ---- | 18.80%278M | ---- | ---- | ---- | ---- | 10.90%234M | ---- | ---- | ---- |
| Rent and land expenses | ---- | 17.64%1.37B | ---- | ---- | ---- | ---- | 2.11%1.16B | ---- | ---- | ---- |
| Other operating expenses | ---- | 7.29%2.6B | ---- | ---- | ---- | ---- | 2.62%2.43B | ---- | ---- | ---- |
| Operating profit | 14.90%902M | -1.60%4.25B | 13.94%1.23B | 2.44%1.22B | -9.19%1.01B | -15.77%785M | -2.82%4.32B | -9.45%1.08B | 1.80%1.19B | 3.45%1.11B |
| Net non-operating interest income (expenses) | 0.00%3M | -18.18%9M | -40.00%3M | 1M | -50.00%2M | 50.00%3M | -66.67%11M | 25.00%5M | 0 | 0.00%4M |
| Non-operating interest income | 0.00%3M | -18.18%9M | -40.00%3M | --1M | -50.00%2M | 50.00%3M | -66.67%11M | 25.00%5M | --0 | 0.00%4M |
| Net investment income | 30.77%255M | 18.63%363M | 40.00%56M | 29.17%93M | -64.81%19M | 39.29%195M | 33.62%306M | 29.03%40M | 26.32%72M | 134.78%54M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 144M | 3M | 129M | 0 | 12M | 0 | 0 | 0 | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -175.00%-11M | -93.10%-112M | -122.73%-49M | 76.00%-6M | -381.82%-53M | -4M | 33.33%-58M | -214.29%-22M | 66.67%-25M | -1,000.00%-11M |
| Less:Other special charges | 175.00%11M | 93.10%112M | 122.73%49M | -76.00%6M | --53M | --4M | -33.33%58M | 214.29%22M | -66.67%25M | ---- |
| Other non-operating income (expenses) | -50.00%1M | -41.67%28M | 200.00%9M | 1,800.00%17M | 0 | 300.00%2M | 1,300.00%48M | -62.50%3M | 92.86%-1M | 1,075.00%47M |
| Income before tax | 15.36%1.15B | 1.28%4.68B | 13.71%1.25B | 17.38%1.45B | -19.02%975M | -7.26%996M | 1.27%4.62B | -10.05%1.1B | 13.38%1.24B | 8.96%1.2B |
| Income tax | 13.51%378M | 4.71%1.56B | 5.47%424M | 16.14%475M | -4.71%324M | -0.60%333M | -3.51%1.49B | -2.66%402M | 9.95%409M | -7.61%340M |
| Net income | 16.31%770M | -0.35%3.12B | 18.60%829M | 18.00%977M | -24.65%651M | -10.42%662M | 3.75%3.13B | -13.81%699M | 15.32%828M | 17.23%864M |
| Net income continuous operations | 16.29%771M | -0.35%3.12B | 18.45%828M | 18.00%977M | -24.65%651M | -10.28%663M | 3.71%3.13B | -13.81%699M | 15.16%828M | 17.23%864M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 16.31%770M | -0.35%3.12B | 18.60%829M | 18.00%977M | -24.65%651M | -10.42%662M | 3.75%3.13B | -13.81%699M | 15.32%828M | 17.23%864M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.31%770M | -0.35%3.12B | 18.60%829M | 18.00%977M | -24.65%651M | -10.42%662M | 3.75%3.13B | -13.81%699M | 15.32%828M | 17.23%864M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 16.37%49.06 | -0.37%198.41 | 18.45%52.71 | 18.06%62.16 | -24.75%41.38 | -10.32%42.16 | 3.45%199.15 | -13.73%44.5 | 14.98%52.65 | 16.98%54.99 |
| Diluted earnings per share | 16.37%49.06 | -0.37%198.41 | 18.57%52.71 | 18.04%62.1505 | -24.70%41.38 | -10.32%42.16 | 3.45%199.15 | -13.82%44.4537 | 14.98%52.65 | 16.89%54.9506 |
| Dividend per share | 0 | 0.00%60 | 0.00%60 | 0 | 0 | 0 | 0.00%60 | 0.00%60 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |